Morphic Holding, Inc.
Morphic Holding, Inc. (MORF) Stock Overview
Key statistics and deep links to earnings, valuation, revenue, dividends, and more.
FMP · MORF · as of Jun 8, 2026
Key Statistics
Explore Morphic Holding, Inc. Data
morf stock data · financialsFinancial Snapshot
Full FinancialsAnalyst Ratings & Price Target
Full ForecastTotal: 9 · Buy rate: 44.4%
The MORF analyst consensus is Hold, based on ratings from 9 Wall Street analysts over the past 3 months. The average 12-month price target is $57.00, representing +0.02% upside from the current price of $56.99.
Competitors & Peers
morf competitorsMORF
BLU
CALT
DICE
FUSN
KDNYStock Performance
Full HistoryAbout Morphic Holding, Inc.
Morphic Holding, Inc. is a biopharmaceutical company dedicated to the discovery and advancement of oral, small-molecule integrin-based therapies. These treatments are designed to address a broad spect…
what is morphic holding, inc. · morf stock overview · morphic holding, inc. company profile · who is morphic holding, inc. ceo · morf NASDAQ · morphic holding, inc. headquarters · morphic holding, inc. business segments
About Stock Overview & Key Data
Morphic Holding, Inc. (MORF) is a Healthcare company in the Biotechnology industry, listed on NASDAQ since Jun 27, 2019. As of the latest trading session, MORF stock price is $56.99, with a market capitalization of $2.9B. The stock has returned +3.39% over the past 12 months and +96.99% year-to-date.
According to 9 Wall Street analysts, the consensus rating for Morphic Holding, Inc. stock is Hold, with an average 12-month price target of $57.00. In fiscal year 2023, Morphic Holding, Inc. reported revenue of $521000.00 and net income of -$152.1M. For detailed data — including Morphic Holding, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.
Frequently Asked Questions
As of the latest trading session, Morphic Holding, Inc. (MORF) stock price is $56.99. The stock is traded on NASDAQ under the ticker symbol MORF. The 52-week range is $19.34 – $57.00.